Eve Health Group Limited has released a press release.
Meluka Sales Performance Drives New Probiotic Product Range
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Earlier from EVE Health
- Appendix 4C - June Quarter 2021 - Amended
- Appendix 4C - June Quarter 2021
- Appendix 4C - March Quarter 2021
- Company Update
- Appendix 4C - December Quarter 2020
Later from EVE Health
- New Probiotic Product Range - Additional Information
- Appendix 4C - September Quarter 2021
- Alliance Agreement - Australian Sales Force
- Alliance Agreement - Additional Information
- Change of Director's Interest Notice x 3
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health